GIA EDGE: Open Payments
NPI 1699150326 · CAPE CORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,285 in 54 payments from 12 companies in 2025. Trend: 2023 $736 · 2024 $857 · 2025 $1,285
Food & beverage: $1,285
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 20 | $589 |
| ABBVIE INC. | 16 | $262 |
| Janssen Biotech, Inc. | 4 | $78 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| Lilly USA, LLC | 2 | $58 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $55 |
| PFIZER INC. | 2 | $37 |
| Galderma Laboratories, L.P. | 1 | $34 |
| GENZYME CORPORATION | 1 | $30 |
| LEO Pharma Inc. | 1 | $30 |
Products named: Zoryve, SKYRIZI, BOTOX, TREMFYA, TALTZ, DUPIXENT, CIBINQO, NEMLUVIO.
Industry payments across FL — which companies pay providers there.
